DK0502146T3 - Marek's sygdom - herpesvirus-DNA-segment, der koder for glycoprotein gE - Google Patents
Marek's sygdom - herpesvirus-DNA-segment, der koder for glycoprotein gEInfo
- Publication number
- DK0502146T3 DK0502146T3 DK91915865T DK91915865T DK0502146T3 DK 0502146 T3 DK0502146 T3 DK 0502146T3 DK 91915865 T DK91915865 T DK 91915865T DK 91915865 T DK91915865 T DK 91915865T DK 0502146 T3 DK0502146 T3 DK 0502146T3
- Authority
- DK
- Denmark
- Prior art keywords
- marek
- disease
- dna segment
- segment encoding
- herpesvirus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/572,711 US5138033A (en) | 1990-08-24 | 1990-08-24 | Marek's disease herpesvirus glycoproteins GE |
US07/736,335 US6087127A (en) | 1990-08-24 | 1991-07-25 | Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE |
PCT/US1991/005870 WO1992003547A1 (en) | 1990-08-24 | 1991-08-19 | MAREK'S DISEASE HERPESVIRUS DNA SEGMENT ENCODING GLYCOPROTEINS, gD, gI AND gE |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0502146T3 true DK0502146T3 (da) | 1998-07-27 |
Family
ID=27075921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91915865T DK0502146T3 (da) | 1990-08-24 | 1991-08-19 | Marek's sygdom - herpesvirus-DNA-segment, der koder for glycoprotein gE |
Country Status (11)
Country | Link |
---|---|
US (2) | US6087127A (da) |
EP (1) | EP0502146B1 (da) |
JP (1) | JP2527872B2 (da) |
AT (1) | ATE160376T1 (da) |
AU (1) | AU636247B2 (da) |
CA (1) | CA2066160A1 (da) |
DE (1) | DE69128239T2 (da) |
DK (1) | DK0502146T3 (da) |
ES (1) | ES2110999T3 (da) |
GR (1) | GR3025821T3 (da) |
WO (1) | WO1992003547A1 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2056565T3 (es) * | 1990-07-30 | 1994-10-01 | Akzo Nobel Nv | Virus recombinante de la enfermedad de marek. |
AU657144B2 (en) * | 1991-07-09 | 1995-03-02 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same |
US6913751B2 (en) * | 1992-06-12 | 2005-07-05 | Schering-Plough Veterinary Corporation | Recombinant avian herpesvirus useful in vaccine production |
US6875856B2 (en) | 1993-09-24 | 2005-04-05 | Syntro Corporation | Recombinant infectious laryngotracheitis virus and uses thereof |
FR2719056B1 (fr) * | 1994-04-20 | 1996-09-06 | Rhone Merieux | Herpesvirus transformés pour exprimer gD in vitro. |
WO1996029396A1 (en) * | 1995-03-23 | 1996-09-26 | Syntro Corporation | Recombinant infectious laryngotracheitis virus and uses thereof |
US7314715B2 (en) | 2001-06-14 | 2008-01-01 | Schering-Plough Animal Health Corporation | Recombinant avian herpesvirus useful in vaccine production |
GB0313132D0 (en) * | 2003-06-06 | 2003-07-09 | Ich Productions Ltd | Peptide ligands |
CN116042709A (zh) * | 2022-09-23 | 2023-05-02 | 广西大学 | 一种共表达马立克病病毒糖蛋白gC和gD的DNA疫苗构建方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3339854B2 (ja) * | 1988-09-13 | 2002-10-28 | メリアル | ウイルスワクチン |
ES2056565T3 (es) * | 1990-07-30 | 1994-10-01 | Akzo Nobel Nv | Virus recombinante de la enfermedad de marek. |
FR2666589B1 (fr) * | 1990-09-07 | 1994-08-05 | Rhone Merieux | Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede. |
PT623172E (pt) * | 1992-01-13 | 2005-02-28 | Virogenetics Corp | Vacina de virus vaccinia recombinante do virus da doenca de marek |
-
1991
- 1991-07-25 US US07/736,335 patent/US6087127A/en not_active Expired - Fee Related
- 1991-08-19 AT AT91915865T patent/ATE160376T1/de active
- 1991-08-19 EP EP91915865A patent/EP0502146B1/en not_active Expired - Lifetime
- 1991-08-19 AU AU84965/91A patent/AU636247B2/en not_active Ceased
- 1991-08-19 CA CA002066160A patent/CA2066160A1/en not_active Abandoned
- 1991-08-19 JP JP3514685A patent/JP2527872B2/ja not_active Expired - Lifetime
- 1991-08-19 DE DE69128239T patent/DE69128239T2/de not_active Expired - Fee Related
- 1991-08-19 WO PCT/US1991/005870 patent/WO1992003547A1/en active IP Right Grant
- 1991-08-19 ES ES91915865T patent/ES2110999T3/es not_active Expired - Lifetime
- 1991-08-19 DK DK91915865T patent/DK0502146T3/da active
-
1997
- 1997-12-30 GR GR970403471T patent/GR3025821T3/el unknown
-
1998
- 1998-03-24 US US09/047,125 patent/US5976787A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH04505106A (ja) | 1992-09-10 |
ATE160376T1 (de) | 1997-12-15 |
US6087127A (en) | 2000-07-11 |
US5976787A (en) | 1999-11-02 |
WO1992003547A1 (en) | 1992-03-05 |
DE69128239T2 (de) | 1998-03-12 |
GR3025821T3 (en) | 1998-03-31 |
DE69128239D1 (de) | 1998-01-02 |
EP0502146B1 (en) | 1997-11-19 |
ES2110999T3 (es) | 1998-03-01 |
JP2527872B2 (ja) | 1996-08-28 |
AU8496591A (en) | 1992-03-17 |
AU636247B2 (en) | 1993-04-22 |
CA2066160A1 (en) | 1992-02-25 |
EP0502146A1 (en) | 1992-09-09 |
EP0502146A4 (da) | 1994-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE258188T1 (de) | Retro-, inverso-, und retro-inverso synthetische peptidanaloge | |
ES2193133T3 (es) | Uso de peptidos derivados de los genes e6 y e7 de hpv-16 para fines. | |
ATE267211T1 (de) | Impfstoff gegen hpv | |
EP0841941A4 (en) | NEW NON-PYROGENIC BACTERIAL STRAINS AND USE OF SUCH STRAINS | |
ATE369428T1 (de) | Behandlung von gebärmutterhalskrebs | |
DE69637942D1 (de) | Stimulationsfaktor für dendriten | |
DK0502146T3 (da) | Marek's sygdom - herpesvirus-DNA-segment, der koder for glycoprotein gE | |
ATE105334T1 (de) | Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3. | |
DE3682893D1 (de) | Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen. | |
PT586076E (pt) | Vacinas de adenovirus recombinantes | |
ATE159170T1 (de) | Impfstoffe und diagnosetest für haemophilus influenzae | |
HUP9901005A2 (hu) | Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B | |
ATE73349T1 (de) | Hepatitisoberflaechenantigenpartikelvakzin. | |
ATE223492T1 (de) | Mutanten des infektiösen rinder rhinotracheitis- virus und impfstoffe | |
EP0432220A4 (en) | Vaccines and diagnostic assays for haemophilus influenzae | |
DE69033810D1 (de) | Herstellung und verwendung des menschlichen nm23-h2-proteins und dagegen gerichtete antikörper | |
MX9602256A (es) | Vacuna contra la enfermedad de marek. | |
OA09653A (en) | Rubella peptides | |
DE3688638D1 (de) | Monoklonale antikoerper fuer humane lungenkarzinome des "nicht-kleine-zellen"-typs. | |
DE69315341D1 (de) | Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen. | |
DE3884672D1 (de) | Ein synthetisches Nonapeptid zur Verwendung als Adjuvant. | |
DE69119785D1 (de) | Zweiphasensystem zur herstellung und präsentation von fremdantigenen in hybriden lebendimpfstoffen | |
DK257887A (da) | Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden | |
ATE86308T1 (de) | Menschlicher b-lymphotroper virus (hblv), isolierung und erzeugnisse. | |
ES2074965A1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. |